SourceOne Partners with Nutri Pharmaceuticals in Powder Technology

November 6, 2008

SourceOne (Chicago) has partnered with Nutri Pharmaceuticals Research (Las Vegas) to develop powder forms of Source’s products with the hopes to broaden the company’s appeal in the nutritional market.

SourceOne (Chicago) has partnered with Nutri Pharmaceuticals Research (Las Vegas) to develop powder forms of Source’s products with the hopes to broaden the company’s appeal in the nutritional market.

Both companies “share the same vision for delivering greater value and broader functionality of exceptional health and wellness ingredients and formulas through innovative application technology. We like to say that we transform good ingredients into great ingredients,” said NPRI CEO, Godfrey Yew.

This new partnership will allow SourceOne to alter the form of products like CoQsource Coenzyme Q10 and OmegaChoice Concentrated Omega-3 Essential Fatty Acids (EFAs) in free-flowing powders, using NPRI’s oil-to-powder technology, according to Jesse Lopez, SourceOne CEO.

“The synergies created by these partnerships are directly and immediately applicable to SourceOne ingredients and formulas in various forms and concentrations,” said Lopez.